The metabolic syndrome: A deadly heart disease continuum. New avenues to understanding this syndrome;Síndrome metabólico, el continuum cardioletal. Nuevos aportes para su comprensión

Salud(i)Ciencia

Volumn 16, Issue 7, 2009, Pages 735-740

  Morales Villegas, Enrique C ^a  

^a Centro de Investigaciones de Óptica   (Mexico)

Author keywords

Adiponectin; Dysfunctional adipocytes; Fetal glycosylated hemoglobin; Insulin resistance; Metabolic syndrome

Indexed keywords

ABDOMINAL OBESITY; ECONOMICS; HEART DISEASE; HUMAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MALNUTRITION; METABOLIC SYNDROME X; PATHOGENESIS; PLACENTA DISORDER; POPULATION; REVIEW;

EID: 68949114009     PISSN: 16678982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hattersley AT, Tooke JE. The fetal insulin hypothesis: An alternative explanation of the association of low birthweigth with diabetes and vascular disease. Lancet 353:1789-1792.
2. Barker DJ, Bagby SP. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 16:2537-2544, 2005.
3. Pfab T, Slowinski T, Godes M, Halle H, Priem F, Hocher B. Low birth weigth, a risk factor for cardiovascular diseases in later life, is already associated with elevated fetal glycosylated hemoglobin at birth. Circulation 114:1687-11682,2006. (Pubitemid 44607116)
4. Ludwing DS. Childhood obesity. The shape of things to come. N Engl J Med 357:2325-2327,2007. (Pubitemid 350223386)
5. Baker J, Olsen LW, Sorensen TIA. Childhood body mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329-2337, 2007. (Pubitemid 350223387)
6. Domingo KB, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med 357:2371-2379,2007. (Pubitemid 350244535)
7. Dekker JM, Girman C, Rhodes T, Nijpels G, Stenhouwer CDA, Bouter LM, Heine RJ. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 112:666-673, 2005. (Pubitemid 41099045)
8. Wilson PWF, D Ágostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072, 2005. (Pubitemid 43113437)
9. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I, Day N, Khaw KT. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation into Cancer and Nutrition in Norfolk cohort. Circulation 116:2933-2943,2007. (Pubitemid 350291200)
10. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366:1640-1649,2005. (Pubitemid 41552419)
11. Morales Villegas E. Síndrome X vs Síndrome Metabólico. Entendiendo sus coincidencias y diferencias hacia una «nueva cardiología». Arch Cardiol Mex 76 (Suppl 4): 173-188, 2006.
12. Taskinen MR. Editorial. Is metabolic syndrome the main threat to human health in the twenty-first century. Atheroscler Thromb Vase Biol 27:2275, 2007.
13. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggarvates inflamatory changes. Role of free fatty acids and tumor necrosis factor alfa. Arterioscler Thromb Vase Biol 25:2062-2068, 2005.
14. Gustafson B, Hammarstedt A, Anderson CX, Smith U. Inflamed adipose tissue. A culprit underlying the metabolic syndrome and atherosclerosis. Atheroscler Thromb Vase Biol 27:2276-2283, 2007.
15. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11-18, 2007.
16. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, HottaK, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradogical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999. (Pubitemid 29299050)
17. Dyck JRB. Editorial. The ischemic heart. Starving to stimulate the adiponectin-AMPk signaling axis. Circulation 116:2779-2781, 2007.
18. Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116:2809-2817, 2007. (Pubitemid 350291223)
19. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo Ch, Shin HK, Moskowitz A. Ouchi N. Adiponectin prevents cerebral-ischemic injury through endothelial nitric oxide synthase-dependent mechanisms. Circulation 117:216-223, 2008.
20. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, lnoue T, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309,2004. (Pubitemid 38082655)
21. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026,2003. (Pubitemid 37377262)